Clorox (CLX) Falls Sharply as COVID-19 Demand Wanes
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq end lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Clorox (CLX) Misses Q4 EPS by 41c, Guidance Falls Short of Consensus
August 3, 2021 6:36 AM EDTClorox (NYSE: CLX) reported Q4 EPS of $0.95, $0.41 worse than the analyst estimate of $1.36. Revenue for the quarter came in at $1.8 billion versus the consensus estimate of $1.92 billion.
GUIDANCE:
Clorox sees FY2022 EPS of $5.40-$5.70, versus the consensus of $7.61.
2% to... More